Results 141 to 150 of about 191,162 (262)

Comparison of the Effects of Strontium Ranelate and Raloxiphene on Bone Mineral Density in Postmenopausal Osteoporosis - Original Investigation

open access: yes, 2009
Aim: To compare the effects of one year- long strontium ranelate (SR) and raloxiphene ( R) therapies on bone mineral densities (BMDs) in postmenopausal osteoporotic women.
Banu Kuran   +4 more
core  

Resveratrol Modulates Bone Metabolism Through SIRT1‐Mediated NF‐κB Inhibition: Molecular Mechanisms and Therapeutic Implications

open access: yesCell Biochemistry and Function, Volume 44, Issue 11, November 2026.
ABSTRACT Osteoporosis and associated skeletal pathologies impose a staggering global health burden, disproportionately impacting elderly populations and postmenopausal women. At the root of excessive bone resorption and stalled osteogenesis lie persistent oxidative stress and chronic inflammation.
Seyyed Hossein Khatami   +11 more
wiley   +1 more source

Estimating the prevalence of osteoporosis in Australia [PDF]

open access: yes, 2014
This report presents information about the prevalence and impact of osteoporosis in Australians aged 50 and over. Summary Osteoporosis, a common condition among older people, causes bones to become weak.

core  

Leuprorelin Suppresses Angiogenesis and Malignant Progression in Endometrial Cancer via Downregulation of the ELAVL1/VEGFA Axis

open access: yesJournal of Biochemical and Molecular Toxicology, Volume 40, Issue 11, November 2026.
Mechanistically, leuprorelin downregulates ELAVL1 expression, which in turn destabilizes VEGFA mRNA and decreases VEGFA protein expression. Functional assays demonstrated that this regulatory axis significantly suppressed EC cell proliferation and migration, promoted apoptosis, and inhibited HUVEC tube formation.
NingNing Zhang, Fang Zhao, LiMei Tan
wiley   +1 more source

The Effect of Yoga Education on Balance and Quality of Life in Postmenopausal Osteoporosis

open access: yes, 2004
Osteoporotic vertebra and hip fractures are major cause of dysfunction, disability, mortality and loss of life quality in our growing and ageing population.
Sevtap Sipahi   +4 more
core  

A critical structured review of economic evaluations of interventions for the prevention and treatment of osteoporosis [PDF]

open access: yes
Osteoporosis is a major cause of morbidity, mortality and resource cost amongst the elderly population. Hip fracture is the most serious of the osteoporotic fractures, with approximately 10-20% of patients dying within six months of sustaining a fracture.
Bernie O'Brien   +3 more
core  

Neutrophils: Heterogeneity, Biology, Diseases, and Therapeutic Strategies

open access: yesMedComm, Volume 7, Issue 11, November 2026.
Neutrophils exhibit remarkable functional plasticity and play dual roles in tissue protection and disease progression. This review summarizes their key biological functions and highlights the shift from conventional broad‐spectrum interventions to neutrophil‐based drug delivery systems.
Yibing Zhang   +4 more
wiley   +1 more source

Diffuse cranial vault hyperostosis associated with long‐term antiepileptic therapy: Autopsy findings and differential diagnostic considerations

open access: yesJournal of Forensic Sciences, Volume 71, Issue 6, Page 2981-2986, November 2026.
Abstract Diffuse cranial vault hyperostosis is an uncommon finding and may present a diagnostic challenge in clinical and forensic practice. We report the case of a 53‐year‐old woman with a long‐standing history of epilepsy treated with phenytoin and sodium valproate who collapsed at home suddenly and died despite resuscitative efforts.
Maria Piagkou   +7 more
wiley   +1 more source

The Effects of Risedronate Therapy Combined With Vitamin D and Calcium on Biochemical Markers of Bone Turnover and Bone Mineral Density in Postmenopausal Osteoporosis

open access: yes, 2004
The aim of the study was to investigate the effects of risedronate therapy combined with vitamin D and calcium on bone mineral density(BMD) and biochemical markers of bone turnover in patients with primary postmenopausal osteoporosis.
Sacide Atalay   +5 more
core  

Bone Anabolic Treatment in Patients With Chronic Kidney Disease: A Systematic Review

open access: yesBasic &Clinical Pharmacology &Toxicology, Volume 139, Issue 5, November 2026.
ABSTRACT Background Chronic kidney disease (CKD) associated osteoporosis leads to an increased risk of bone fracture in patients with CKD. Evidence on the efficacy and safety of anti‐osteoporotic medications is limited for this group. This systematic review aimed to examine the efficacy and safety of anabolic parathyroid hormone (PTH) treatment in ...
Huriye Seyma Kafa   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy